Tobramycin / dexamethasone
Anti-inflammatory · Rx
RxAnti-inflammatorySteroid
| Strength | Tobramycin 0.3% + dexamethasone 0.1% (ST 0.05%) |
|---|---|
| Typical quantity | 2.5-5 mL bottle (generic available) |
| Cash cost / month | Moderate · ~$20-100 |
| Drug class | Antibiotic + corticosteroid (combination) |
| Mechanism of action | Aminoglycoside antibacterial cover plus potent corticosteroid anti-inflammatory. |
| Indication / reason for use | Steroid-responsive inflammation where a bacterial infection or risk exists, blepharoconjunctivitis, marginal keratitis, post-op, chalazion adjunct. |
| Usual adult dosing | 1-2 drops q4-6h (up to q2h initially); ointment TID-QID. Shake suspension. |
| Preservative | BAK 0.01% |
| Contact lenses | Do not wear lenses during treatment. |
| Common / important adverse effects | IOP elevation, cataract with prolonged use, aminoglycoside surface toxicity, masking/worsening of undiagnosed HSV or fungal infection. |
| Contraindications & cautions | Epithelial herpes simplex keratitis, fungal/mycobacterial infection, most viral corneal disease. |
| Pregnancy / lactation | Limited data. |
| Pregnancy category (older labels) | No letter category on the current label. From DailyMed labels, checked Nov 2026. |
| Trade names | TobraDex, TobraDex ST |
| Practice notes | Reassess by 1-2 weeks; not for undiagnosed red eye or presumed viral conjunctivitis. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.